Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Votion 2013 Abstract MiP2013

From Bioblast
Revision as of 10:27, 9 July 2013 by Bidaurratzaga Eider (talk | contribs) (Created page with "{{Abstract |title=Votion DM, Mouithys-Mickalad A, Ceusters J, Lemieux H, Tosi I, Franck T, Art T, Niesten A, Serteyn D(2013) The challenge of understanding myopathies in horses u...")
(diff) โ† Older revision | Latest revision (diff) | Newer revision โ†’ (diff)
Votion DM, Mouithys-Mickalad A, Ceusters J, Lemieux H, Tosi I, Franck T, Art T, Niesten A, Serteyn D(2013) The challenge of understanding myopathies in horses using permeabilized muscle cells. Mitochondr Physiol Network 18.08.

Link:

Votion DM, Mouithys-Mickalad A, Ceusters J, Lemieux H, Tosi I, Franck T, Art T, Niesten A, Serteyn D (2013)

Event: MiP2013

Text


Labels:








Affiliations and author contributions

1 - Equine Clinic, Faculty of Veterinary Medicine, University of Liege, Belgium;

2 - Center for Oxygen Research and Development (CORD), Institute of Chemistry, University of Liege, Belgium;

3 - Campus Saint-Jean, University of Alberta, Edmonton, Canada.

Email: [email protected]

References

  1. McCue ME, Valberg SJ, Miller MB, Wade C, DiMauro S, Akman HO, Mickelson, JR (2008) Glycogen synthase (GYS1) mutation causes a novel skeletal muscle glycogenosis. Genomics 91: 458-466.
  2. Votion DM, Van Galen G, Sweetman L, Boemer F, de Tullio P, Dopagne C, Lefรจre L, Mouihys-Mickalad A, Patarin F, Rouxhet S, Van Loon G, Serteyn D, Sponseller BT, Valberg SJ (2013) The toxic metabolite causing equine atypical myopathy in europe has been identified. Submitted.
  3. Votion DM, Gnaiger E, Lemieux H, Mouithys-Mickalad A, Serteyn D (2012) Physical fitness and mitochondrial respiratory capacity in horse skeletal muscle. PLoS One 7: e34890.